Drug maker Novo Nordisk expects lower US prices next year

Drug maker Novo Nordisk expects lower US prices next year


Novo Nordisk, the world's top maker of diabetes drugs, on Wednesday reported second-quarter operating profit broadly in line with forecasts, but said prices in the key U.S. market would be lower next year. FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres, north-central France, April 21, 2016.



from Biotech News